chuminhua2020-11-18 14:58
11/17,BrainStorm Cell Therapeutics表示,一项评估细胞疗法NurOwn作为肌萎缩侧索硬化症(ALS)患者治疗方法的III期研究未能达到主要疗效终点的显著性指标,导致该公司股价跌幅高达68%。该公司补充说,虽然NurOwn在主要终点以及关键的次要疗效终点上都有数值上的改善,但与安慰剂相比,这些改善都不...查看全文
$BrainStorm Cell(BCLI)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001104659-24-082328 Size: 7 KB 网页链接
$BrainStorm Cell(BCLI)$ 8-K Current report, item 3.01 Accession Number: 0001104659-24-081162 Act: 34 Size: 206 KB 网页链接
$BrainStorm Cell(BCLI)$ 424B5 Prospectus [Rule 424(b)(5)] Accession Number: 0001104659-24-076128 Act: 33 Size: 374 KB 网页链接
$BrainStorm Cell(BCLI)$ 8-K Current report, items 1.01, 3.02, 8.01, and 9.01 Accession Number: 0001104659-24-075995 Act: 34 Size: 1 MB 网页链接
$BrainStorm Cell(BCLI)$ 424B5 Prospectus [Rule 424(b)(5)] Accession Number: 0001104659-24-075416 Act: 33 Size: 9 KB 网页链接
$BrainStorm Cell(BCLI)$ 8-K Current report, items 8.01 and 9.01 Accession Number: 0001104659-24-075146 Act: 34 Size: 211 KB 网页链接
$BrainStorm Cell(BCLI)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001104659-24-074873 Size: 8 KB 网页链接
$BrainStorm Cell(BCLI)$ 3 Initial statement of beneficial ownership of securities Accession Number: 0001104659-24-074871 Size: 3 KB 网页链接
$BrainStorm Cell(BCLI)$ 8-K Current report, items 5.02 and 9.01 Accession Number: 0001104659-24-073484 Act: 34 Size: 228 KB 网页链接
$BrainStorm Cell(BCLI)$ 8-K Current report, item 3.01 Accession Number: 0001104659-24-068007 Act: 34 Size: 203 KB 网页链接